[Skip to Content]
[Skip to Content Landing]
September 1984

Economical Use of Nonsteroidal Anti-inflammatory Drugs

Author Affiliations

Jacksonville, Fla

Arch Intern Med. 1984;144(9):1897. doi:10.1001/archinte.1984.00350210227053

To the Editor.  —In 1983 our hospital prescribed $282,000 worth of nonsteroidal anti-inflammatory drugs (NSAIDs). By cost analysis, three of the top five medications prescribed were NSAIDs.We recently surveyed 100 NSAID prescriptions that were written for a quantity greater than a two-week supply of these medications. The NSAIDs evaluated were ibuprofen, indomethacin, naproxen, piroxicam, sulindac, and tolmetin. Patients were questioned by telephone seven to ten weeks after receiving the medication.Seventy-three percent of the patients stated that they had tried a similar agent but had discontinued its use because of ineffectiveness (79%) or side effects (21%). Of those patients who could clearly recall, 76% admitted discarding or not using a portion of the NSAID prescribed in the past. The current prescription was classified as effective by 78% of those surveyed.The prescribing of these medications is largely based on therapeutic trials, consequently, much waste is inherent. Even if one

First Page Preview View Large
First page PDF preview
First page PDF preview